Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study is to prospectively assess the anti-depressant effectiveness of reboxetine in children and adolescents, as compared with fluoxetine, in a randomized controlled open-label trial.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Geha Mental Health Center
• Treatments: Reboxetine

Criteria

Inclusion Criteria:

• A diagnosis of major depressive disorder or a dysthimic disorder according to DSM-IV-TR.

• Drug naïve or without chronic medication for at least one month.

• Only children who agree to participate and whose parents will sign and informed consent form will be included.

Exclusion Criteria:

• A diagnosis of a psychotic disorder or bipolar disorder.

• Mental retardation.

• Alcohol or drug abuse

• Chronic medical condition

• Girls (> 12 years) will not be included in the study if a possibility of pregnancy during the study exists.